InsidersTradesSigma
Discover the detailed record of transactions filed by Hineline Lawrence J., Chief Financial Officer. Director active across 1 companies, notably Intra-Cellular Therapies, Inc.. In total, 6 filings have been logged. The latest transaction was disclosed on 21 December 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
6 of 6 declarations
Lawrence J. Hineline is the Chief Financial Officer and Senior Vice President of Finance at Intra-Cellular Therapies, Inc. He oversees the financial management of the company, including financial reporting, budgeting, and financing strategies.